Maa: Yhdysvallat
Kieli: englanti
Lähde: NLM (National Library of Medicine)
ATIPAMEZOLE HYDROCHLORIDE (UNII: 2W4279571X) (ATIPAMEZOLE - UNII:03N9U5JAF6)
ASPEN VETERINARY RESOURCES®, LTD
INTRAMUSCULAR
PRESCRIPTION
Revertased™ is indicated for the reversal of the sedative and analgesic effects of dexmedetomidine hydrochloride, and medetomidine hydrochloride in dogs. Since atipamezole is always used concomitantly with dexmedetomidine or medetomidine, it should not be used in dogs with the following conditions: cardiac disease, respiratory disorders, liver or kidney diseases, dogs in shock, severely debilitated dogs, or dogs stressed due to extreme heat, cold or fatigue. Administration of atipamezole is contraindicated in dogs with a known hypersensitivity to the drug.
Revertased™ is supplied in 10-mL, multidose vials containing 5.0 mg of atipamezole hydrochloride per mL. Approved by FDA under ANADA # 200-753 Manufactured for: Aspen Veterinary Resources®, LTD. Liberty, MO 64068 pivetalvet.com info@aspenveterinaryresources.com
Abbreviated New Animal Drug Application
REVERTASED- ATIPAMEZOLE HYDROCHLORIDE INJECTION, SOLUTION ASPEN VETERINARY RESOURCES®, LTD ---------- REVERTASED™ (ATIPAMEZOLE HYDROCHLORIDE) STERILE INJECTABLE SOLUTION - 5.0 MG/ML _Dexmedetomidine and Medetomidine Reversing Agent_ _For intramuscular use in dogs only_ CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION Revertased™ (atipamezole hydrochloride) is a synthetic α -adrenergic antagonist. The chemical name is 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole hydrochloride. The molecular formula is C H N • HCl and structural formula is: Each mL of Revertased™ contains 5.0 mg atipamezole hydrochloride, 1.0 mg methylparaben (NF), 8.5 mg sodium chloride (USP), and water for injection (USP). INDICATIONS Revertased™ is indicated for the reversal of the sedative and analgesic effects of dexmedetomidine hydrochloride, and medetomidine hydrochloride in dogs. DOSAGE AND ADMINISTRATION Revertased™ is administered intramuscularly (IM) for reversal of sedation and analgesia regardless of the route used for dexmedetomidine hydrochloride or medetomidine hydrochloride. The atipamezole dose for the reversal of IV dexmedetomidine hydrochloride or medetomidine hydrochloride is 3750 mcg/m . The atipamezole dose for the reversal of IM dexmedetomidine hydrochloride or medetomidine hydrochloride is 5000 mcg/m . 2 14 16 2 2 2 The dosage of Revertased™ is calculated based on body surface area. Use the following tables to determine the correct injection volume or the correct Revertased™ dosage on the basis of kilograms of body weight. NOTE THAT THE MCG/KG DOSAGE DECREASES AS BODY WEIGHT INCREASES. TABLE 1: ATIPAMEZOLE DOSING FOR REVERSAL OF IV DEXMEDETOMIDINE- OR MEDETOMIDINE-INDUCED SEDATION/ANALGESIA: DOSE TABLE FOR REVERTASED™ (3750 MCG/M ) WHEN DEXMEDETOMIDINE OR MEDETOMIDINE IS GIVEN IV FOR # LBS FOR # KG DOSE = MCG/KG VOLUME = ML REVERTASED™ 4-7 2-3 300 0.1 7-9 3-4 250 0.15 9-11 4-5 230 0.2 11-22 5-10 200 0.3 22-33 10-15 170 0.4 33-44 15-20 150 0 Lue koko asiakirja